Skip to the page

Data / Drug companies / Eucalyptus globulus

Eucalyptus globulus: 5 companies and 14 products in the FDA NDC directory

Eucalyptus globulus is listed in the FDA National Drug Code Directory by 5 companies, with 14 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are pellet; solution; liquid, and the newest product started marketing on December 20, 2023.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
5
Products
14
Generic (ANDA) products
0 (0.0%)
Application numbers
3
Routes
Oral, Intradermal, Percutaneous, Subcutaneous, Topical
Brand names
Bluegum Eucalyptus Pollen, Dermveda Complete Lice Treatment Natural Serum, Eucalyptus Pollen
openFDA record search
api.fda.gov

Companies that list eucalyptus globulus

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Hahnemann Laboratories, Inc.7pelletUnapproved homeopathic productsJune 21, 2022
Greer Laboratories, Inc.4solutionBiologics (BLA)September 15, 1981
Allermed Laboratories, Inc.1injectionBiologics (BLA)March 12, 1974
Celcius Corp.1liquidUnapproved homeopathic productsDecember 20, 2023
Jubilant HollisterStier LLC1injection, solutionBiologics (BLA)April 19, 1941

Dosage forms

Dosage formProductsShare
Pellet750%
Solution428.6%
Liquid17.1%
Injection17.1%
Injection, solution17.1%

Marketing categories

Marketing categoryProductsShare
Unapproved homeopathic products857.1%
Biologics (BLA)642.9%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.